Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<IPO>Singapore's Hummingbird Bioscience Reportedly Plans to List in HK Next Yr
Recommend 13 Positive 19 Negative 13 |
||||
|
||||
|
Singapore's biopharmaceutical company Hummingbird Bioscience is weighing a listing in Hong Kong next year, Reuters' IFR reported, citing sources. The company, founded in 2015, focuses on developing innovative cancer treatment drugs. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
